Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Decoding and Modulating Affective Brain States

NCT: NCT05437705 · RECRUITING

NCT IDNCT05437705
StatusRECRUITING
Start Date2023-02-21
Completion2029-12-01
SponsorUniversity of Pennsylvania (OTHER)
First posted
Last updated

Brief Summary

The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, the investigators will use functional Magnetic Resonance Imaging (fMRI) data to generate a negative affect map for each participant. Then, the investigators will apply a variety of repetitive transcranial magnetic stimulation (rTMS) sequences while the participant is inside the MRI scanner to determine the optimal and least optimal rTMS frequencies at changing negative affect brain states. Finally, these two frequencies will be tested over two 3-day rTMS neuromodulation sessions to assess whether they can reduce negative emotions.

Frequently Asked Questions

What is Decoding and Modulating Affective Brain States?

Decoding and Modulating Affective Brain States is a clinical trial registered under NCT05437705. Current status: RECRUITING.

What is the status of NCT05437705?

The current status of NCT05437705 (Decoding and Modulating Affective Brain States) is: RECRUITING.

When did Decoding and Modulating Affective Brain States start?

Decoding and Modulating Affective Brain States started on 2023-02-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.